[go: up one dir, main page]

SI9720060B - Use of 2-phenyl-1, 2-benzisoselenazol-3(2h)-one for producing a pharmaceutical preparation intended for treatment of the alzheimer's disease - Google Patents

Use of 2-phenyl-1, 2-benzisoselenazol-3(2h)-one for producing a pharmaceutical preparation intended for treatment of the alzheimer's disease Download PDF

Info

Publication number
SI9720060B
SI9720060B SI9720060A SI9720060A SI9720060B SI 9720060 B SI9720060 B SI 9720060B SI 9720060 A SI9720060 A SI 9720060A SI 9720060 A SI9720060 A SI 9720060A SI 9720060 B SI9720060 B SI 9720060B
Authority
SI
Slovenia
Prior art keywords
alzheimer
phenyl
treatment
pharmaceutical preparation
benzisoselenazol
Prior art date
Application number
SI9720060A
Other languages
English (en)
Other versions
SI9720060A (sl
Inventor
Ikuro Maruyama
Kazuhiro Abeyama
Hiroyuki Masayasu
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of SI9720060A publication Critical patent/SI9720060A/sl
Publication of SI9720060B publication Critical patent/SI9720060B/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Claims (3)

1 Patentni zahtevki 1. Uporaba 2-fenil-1,2-benzizoselenazol-3(2H)-ona za pripravo farmacevtskega pripravka za profilakso in/ali terapijo demence.
2. Uporaba po zahtevku 1 za pripravo farmacevtskega pripravka za profilakso in/ali terapijo senilne demence.
3. Uporaba po zahtevku 1 ali 2 za pripravo farmacevtskega pripravka za profilakso ; in/ali terapijo demence Alzheimerjevega tipa.
SI9720060A 1996-08-27 1997-04-07 Use of 2-phenyl-1, 2-benzisoselenazol-3(2h)-one for producing a pharmaceutical preparation intended for treatment of the alzheimer's disease SI9720060B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22551296 1996-08-27
PCT/DE1997/000701 WO1998008511A1 (de) 1996-08-27 1997-04-07 Verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-one zur herstellung einer pharmazeutischen zubereitung für die behandlung der alzheimer-krankheit

Publications (2)

Publication Number Publication Date
SI9720060A SI9720060A (sl) 1999-06-30
SI9720060B true SI9720060B (en) 2001-12-31

Family

ID=16830487

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9720060A SI9720060B (en) 1996-08-27 1997-04-07 Use of 2-phenyl-1, 2-benzisoselenazol-3(2h)-one for producing a pharmaceutical preparation intended for treatment of the alzheimer's disease

Country Status (28)

Country Link
US (1) US5948800A (sl)
EP (1) EP0826370B1 (sl)
KR (1) KR20000035859A (sl)
CN (1) CN1112922C (sl)
AT (1) ATE219361T1 (sl)
AU (2) AU3866997A (sl)
BR (1) BR9711259A (sl)
CA (1) CA2213794C (sl)
CZ (1) CZ295364B6 (sl)
DE (2) DE59707550D1 (sl)
DK (1) DK0826370T3 (sl)
EE (1) EE03953B1 (sl)
ES (1) ES2177849T3 (sl)
FI (1) FI119622B (sl)
HU (1) HU225264B1 (sl)
IL (1) IL127113A (sl)
LT (1) LT4602B (sl)
LV (1) LV12251B (sl)
NO (1) NO312812B1 (sl)
NZ (1) NZ332292A (sl)
PL (1) PL188481B1 (sl)
PT (1) PT826370E (sl)
SI (1) SI9720060B (sl)
TR (1) TR199700858A2 (sl)
TW (1) TW501925B (sl)
UA (1) UA59367C2 (sl)
WO (2) WO1998008511A1 (sl)
ZA (1) ZA977644B (sl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69328128T2 (de) * 1993-10-27 2000-08-24 Daiichi Pharmaceutical Co., Ltd. Granuläre zubereitung
JP2000016935A (ja) 1998-07-01 2000-01-18 Dai Ichi Seiyaku Co Ltd シクロオキシゲナーゼ阻害剤
AU3457300A (en) * 1999-03-31 2000-10-16 Daiichi Pharmaceutical Co., Ltd. Substrates for thioredoxin reductase
WO2003010154A1 (en) * 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses
WO2003010153A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
WO2003010143A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co., Ltd. Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
CN103965188A (zh) * 2013-01-29 2014-08-06 中山大学 含硒多奈哌齐类似物
EP2950102A1 (en) 2014-05-30 2015-12-02 Biocross, S.L. Method for the diagnosis of alzheimer s disease and mild cognitive impairment
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
EP3067699A1 (en) 2015-03-11 2016-09-14 Neuron Bio, S.A. Method for diagnosing alzheimer's disease
PL237739B1 (pl) 2018-06-06 2021-05-17 Univ Gdanski Genisteina do zastosowania do leczenia choroby Alzheimera
CN113116888B (zh) * 2021-04-19 2022-08-26 上海兴糖生物技术有限公司 依布硒啉的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3616923A1 (de) * 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3638124C2 (de) * 1986-11-08 1996-09-05 Nattermann A & Cie Neue pharmazeutische Verwendung von Ebselen
JPH01131113A (ja) * 1987-08-27 1989-05-24 Dai Ichi Seiyaku Co Ltd 脳障害治療剤
JPH0238591A (ja) 1988-07-27 1990-02-07 Fujikura Ltd 高純度銅の製造方法
DE4024885C2 (de) * 1990-08-06 2002-07-18 Nattermann A & Cie Verwendung von 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
US5385726A (en) * 1990-08-06 1995-01-31 Rhone-Poulenc Rorer Gmbh Use of 2-phenyl-1,2-benzisoselenazol-3-(2H)-one
FR2669633B1 (fr) * 1990-11-23 1993-01-22 Adir Nouveaux derives de la benzoselenazolinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
JPH07233056A (ja) * 1993-09-03 1995-09-05 Dai Ichi Seiyaku Co Ltd リポキシゲナーゼ阻害剤

Also Published As

Publication number Publication date
KR20000035859A (ko) 2000-06-26
HUP9903213A3 (en) 2000-12-28
TR199700858A2 (xx) 1998-03-21
WO1998008511A1 (de) 1998-03-05
IL127113A (en) 2003-07-06
LV12251A (lv) 1999-04-20
AU3529897A (en) 1998-03-05
ES2177849T3 (es) 2002-12-16
LV12251B (lv) 1999-08-20
EE9900007A (et) 1999-06-15
PL321796A1 (en) 1998-03-02
NO973912D0 (no) 1997-08-26
AU725534B2 (en) 2000-10-12
NO973912L (no) 1998-03-02
LT99016A (en) 1999-10-25
HK1020317A1 (en) 2000-04-14
DE59707550D1 (de) 2002-07-25
FI982689L (fi) 1998-12-11
IL127113A0 (en) 1999-09-22
DE19733690A1 (de) 1998-03-26
DK0826370T3 (da) 2002-10-07
EP0826370A1 (de) 1998-03-04
AU3866997A (en) 1998-03-19
EE03953B1 (et) 2003-02-17
FI982689A0 (fi) 1998-12-11
UA59367C2 (uk) 2003-09-15
FI119622B (fi) 2009-01-30
BR9711259A (pt) 1999-08-17
WO1998008831A1 (en) 1998-03-05
TW501925B (en) 2002-09-11
NZ332292A (en) 2001-07-27
PL188481B1 (pl) 2005-02-28
CN1223580A (zh) 1999-07-21
US5948800A (en) 1999-09-07
HU225264B1 (en) 2006-08-28
LT4602B (lt) 2000-01-25
CN1112922C (zh) 2003-07-02
ZA977644B (en) 1999-02-26
PT826370E (pt) 2002-10-31
NO312812B1 (no) 2002-07-08
HUP9903213A1 (en) 2000-07-28
CA2213794A1 (en) 1998-02-27
CZ31799A3 (cs) 1999-11-17
ATE219361T1 (de) 2002-07-15
SI9720060A (sl) 1999-06-30
CZ295364B6 (cs) 2005-07-13
EP0826370B1 (de) 2002-06-19
CA2213794C (en) 2006-10-03

Similar Documents

Publication Publication Date Title
SI9720060B (en) Use of 2-phenyl-1, 2-benzisoselenazol-3(2h)-one for producing a pharmaceutical preparation intended for treatment of the alzheimer's disease
CA2012876A1 (en) Use of 5-methyltetrahydrofolic acid and 5-formyltetrahydrofolic acid in the treatment of organic mental disturbances
CA2191101A1 (en) Materials and methods for treatment of plaquing diseases
DE68923819D1 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
NO20002702L (no) Tienopyrimidiner
ZA905978B (en) Derivatives of 1,2,3,4-tetrahydro-9-acridinamine
ATE193442T1 (de) 3,4-diarylchromane zur behandlung von dermatitis
CA2019231A1 (en) Novel acetylcholinesterase inhibitors
ATE162076T1 (de) Verwendung von nadh und nadph zur herstellung eines arzneimittels zur behandlung von morbus alzheimer
WO2002060435A8 (fr) Cryptotanshinone permettant de prevenir et d'attenuer la maladie d'alzheimer
CA2078700A1 (en) Imidazolylmethyl-pyridines
ZA906057B (en) 4-(n-substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof as centrally acting muscarinic agents
CA2301706A1 (en) Use of phanquinone for the treatment of alzheimer's disease
EP0345247A3 (de) Verwendung von monosubstituierten selenorganischen Verbindungen zur Herstellung eines Arzneimittels sowie daraus hergestelltes Arzneimittel und Verfahren zu seiner Herstellung
GR3022205T3 (en) New derivatives of physostigmine, their use and pharmaceutical formulations containing them
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
MY103216A (en) Nedocromil calcium and use thereof in treatment of reversible obstuctive airways disease
ES2009689A6 (es) Procedimiento para preparar derivados de 3-piperidina-carbaldehido-oxima.
EP0269452A3 (en) Use of ketone derivatives for the manufacture of medicaments
CA2060333A1 (en) Use of pyrimido-benzothiazine derivatives
RU99106244A (ru) Применение 2-фенил-1,2-бензизоселеназол-3(2h)-она для получения фармацевтического препарата для лечения болезни альцгеймера

Legal Events

Date Code Title Description
KO00 Lapse of patent

Effective date: 20041231